1887

oa SA Pharmaceutical Journal - Young Scientist Award 2007 : cum laude

 

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most frequent neurodegenerative disorders and cause of disability among western societies. Interest in the selective inhibition of monoamine oxidase B (MAO-B) has increased in the last years due to their therapeutic potential in this age related neurodegeneration.

Loading

Article metrics loading...

/content/mp_sapj/75/1/EJC81852
2008-01-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error